Author(s):
Naveenkumar R, Kavya HR, Sayani Bhattacharyya
Email(s):
sayanibh@gmail.com
DOI:
10.5958/0974-360X.2021.00087.1 
Address:
Naveenkumar R, Kavya HR, Sayani Bhattacharyya
Department of Pharmaceutics, Krupanidhi College of Pharmacy, No .12/1 Chikkabellandur, Carmelaram Post, Varthur, Hobli. Bangalore 560035.
*Corresponding Author
Published In:
Volume - 14,
Issue - 1,
Year - 2021
ABSTRACT:
Nanotechnology deals with exceptionally minute structures, size ranging from 0.1 to 100 nm. The field of nanomedicine and nanotechnology is currently undergoing explosive developments in various fields of science and other new areas. Properties related to the particle surface and quantum mechanics are the two main aspects that render the nanomedicine functionally different from other bulk formulations. Dermal diseases can be controlled by using the nano approaches which allows an enormous opportunity in designing the novel low dose and effective treatment systems. Therefore, they have received meticulous attention as topical drug delivery systems. The present review considers the anatomy of skin, skin diseases, novel nano-based formulation approaches with evaluation techniques and its applications in various aspects.
Cite this article:
Naveenkumar R, Kavya HR, Sayani Bhattacharyya. Innovative nano approaches in cutaneous delivery of drugs.Research J. Pharm. and Tech. 2021; 14(1):477-481. doi: 10.5958/0974-360X.2021.00087.1
Cite(Electronic):
Naveenkumar R, Kavya HR, Sayani Bhattacharyya. Innovative nano approaches in cutaneous delivery of drugs.Research J. Pharm. and Tech. 2021; 14(1):477-481. doi: 10.5958/0974-360X.2021.00087.1 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-1-87
REFERENCE:
1. Rawlings A, Harding C. Moisturization and skin barrier function. Dermatologic Therapy. 2004; 17: 43–8.
2. Boelsma E, Hendriks HF, Roza L. Nutritional skin care: Health effects of micronutrients and fatty acids. The American Journal of Clinical Nutrition. 2001; 73: 853–64.
3. Van Putte C, Seeley R. Seeley’s Anatomy & Physiology. New York, NY: McGraw-Hill; 2014.
4. Slominski A, Wortsman J. Neuroendocrinology of the Skin 1. Endocrine Reviews. 2000; 21: 457–87.
5. Oaklander AL, Siegel SM. Cutaneous innervation: Form and function. Journal of the American Academy of Dermatology. 2005;
6. Ross MH, Pawlina W. Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2011.
7. Arrowsmith J. A decade of change. Nat Rev Drug Discov. 2012;11(1):17–8.
8. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov. 2011;10(9):712.
9. Summerfield S, Jeffrey P. Discovery DMPK: changing paradigms in the eighties, nineties and noughties. Expert Opin Drug Discov. 2009;4(3):207–18.
10. Huh AJ, Kwon YJ. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Journal of controlled release. 2011 Dec 10;156(2):128-45.
11. Lademann J, Weigmann HJ, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacology and Physiology. 1999;12(5):247-56.
12. Junqueira LCU, Mescher AL. Junqueira’s Basic Histology: Text and Atlas. 13 ed: McGraw-Hill Medical; 2013.
13. Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF, Sahar A, Riley MA, Rotello VM. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano. 2014 Sep 22;8(10):10682-6.
14. Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy, Asthma Clin Immunol [Internet]. 2018Sep12[cited2019Aug9];14(S2):52. Availablefrom:https://aacijournal.biomedcentral.com/articles/10.1186/s13223-018-0281-6
15. Ng KW, Lau WM. Skin deep: the basics of human skin structure and drug penetration. In Percutaneous penetration enhancers chemical methods in penetration enhancement 2015 (pp. 3-11). Springer, Berlin, Heidelberg.
16. Rangasamy M. Nano technology: a review. Journal of Applied Pharmaceutical Science. 2011;1(2):8-16.
17. Bos JD, Meinardi MMHM (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Ex. Dermatol. 9(3): 165–169.
18. Smith H, Clawes H, Marshall E. Mustard gas - IV - the mechanism of absorption by the skin. J Pharmacol Exp Ther. 1919;13:1–30.
19. Feldmann RJ, Maibach HI. Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol. 1967;48(2):181–83.
20. McGrath JA, Eady RA, Pope FM. Anatomy and organization of human skin. Rook’s textbook of dermatology. 2004 Jan 1;10:9781444317633.
21. Fritsch P. Dermatologie und Venerologie. Aufl. Berlin, Heidel-berg. New York: Springer. 2004;65:66.
22. Attama AA, Schicke BC, Paepenmüller T, Müller-Goymann CC (2007) Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: Characterization. Eur. J. Pharm. Biopharm. 67: 48-57.
23. Bernfild M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M (1999) Functions of cell surface heparan sulphate proteoglycans. Annu. Rev. Biochem. 68: 729-777.
24. Riegelman S. Pharmacokinetics; Pharmacokinetic factors affecting epidermal penetration and percutaneous absorption. Clinical Pharmacology & Therapeutics. 1974 Nov;16(5part2):873-83.
25. Mittal A, Raber AS, Schaefer UF, Weissmann S, Ebensen T, Schulze K, Guzmán CA, Lehr CM, Hansen S. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization. Vaccine. 2013 Jul 25;31(34):3442-51.
26. Mittal A, Schulze K, Ebensen T, Weißmann S, Hansen S, Lehr CM, Guzmán CA. Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. Nanomedicine: Nanotechnology, Biology and Medicine. 2015 Jan 1;11(1):147-54.
27. FDA U. Guidance for Industry: topical dermatological drug product NDAs and ANDAs-in vivo bioavailability, bioequivalence, in vitro release, and associated studies. Draft Guidance, June 1998, US Department of Health and Human Services. Food and Drug Administration, Center for Drug Evaluation and Research (CDER). 1998:31-47.
28. Morgan P, et al. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving phase II survival. Drug Discov Today. 2012;17(9–10):419–24.
29. Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40–51.
30. Nair A, Jacob S, Al-Dhubiab B, Attimarad M, Harsha S. Basic considerations in the dermatokinetics of topical formulations. Brazilian journal of pharmaceutical sciences. 2013 Sep;49(3):423-34.
31. Spruance SL. The natural history of recurrent oral-facial herpes simplex virus infection. Semin Dermatol. 1992;11(3):200–6.
32. Wester RC, Bucks DA, Maibach HI. In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers. J Am Acad Dermatol. 1983;8(5):645–7.
33. Selvakumar K, Yadav AV. Nanobased Drug Delivery System: A Review. Res J Pharm Tech.2009; 2(1): 21-27.
34. Uma S K et al. Nanoemulsions - Approaching Thermodynamic Stability. Res J PharmTech. 2010 3(2): 319-26.
35. Scheuplein RJ. A personal view of skin permeation (1960-2013). Skin Pharmacol Physiol. 2013;26(4–6):199–212.
36. Utpal J et al. Nanoparticles: A Potential Approach for Drug Delivery. Res JPharm Tech. 2011; 4(7): 1016-19.
37. Junqueira LCU, Mescher AL. Junqueira’s Basic Histology: Text and Atlas. 13 ed: McGraw-Hill Medical; 2013.
38. https://www.practo.com/medicine-info/oxalgin-nano-1-gel-8308
39. https://www.webmd.com/drugs/drugreview-7713-Aquaphor-topical.aspx?drugid=7713&drugname=Aquaphor-topical
40. https://www.1mg.com/otc/silvercure-nanogel-otc347316?gclid=Cj0KCQjwp5_qBRDBARIsANxdcinqk7t6STvbqGI5KDLKIIzfMe0D8ZewdCVhBb_UMf0LiDCo_o6d2QUaAlaWEALw_wcB
41. https://www.practo.com/medicine-info/nadoxin-1-gel-46801
42. https://www.1mg.com/drugs/nadoxin-a-gel-130146?gclid=CjwKCAjw4ZTqBRBZEiwAHHxpfh62JiGljp7BIXoLrno6IFeydSX2j7uPEy7jxMwAAlByuWfV8pkVqhoCkjsQAvD_BwE
43. https://www.practo.com/medicine-info/soframycin-skin-cream-49766
44. https://www.practo.com/medicine-info/persol-forte-10-cream-33282
45. https://www.webmd.com/vitamins/ai/ingredientmono-1117/thuja
46. https://www.webmd.com/drugs/2/drug-76702/rosac-topical/details
47. https://www.webmd.com/drugs/2/drug-148192/altabax-topical/details
48. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol. 2011;162(6):1239–49.
49. Junqueira LCU, Mescher AL. Junqueira’s Basic Histology: Text and Atlas. 13 ed: McGraw-Hill Medical; 2013.